Hangfei E. Xu - Publications

Aging promotes inflammation and steatosis in alcohol-associated liver disease in mice.

Journal: bioRxiv : the preprint server for biology

Published: July 15, 2026

Multiple Allosteric Sites Allow for Synergistic Enhancement of GPCR Signaling.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Panx1 deficiency exacerbates GAN diet-induced obesity by destabilizing β-catenin via GSK3β.

Journal: iScience

Published: September 18, 2025

Inflammation activity affects liver stiffness measurement by magnetic resonance elastography in MASLD.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: November 20, 2023

Letter: NSBB for fatty liver disease-Still a long way to go.

Journal: Alimentary pharmacology & therapeutics

Published: September 28, 2023

SAMM50-rs2073082, -rs738491 and -rs3761472 Interactions Enhancement of Susceptibility to Non-Alcoholic Fatty Liver Disease.

Journal: Biomedicines

Published: July 19, 2023

PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction.

Journal: International journal of molecular sciences

Published: May 03, 2023

MBOAT7 rs641738 (C>T) is associated with NAFLD progression in men and decreased ASCVD risk in elder Chinese population.

Journal: Frontiers in endocrinology

Published: April 03, 2023

Spleen stiffness determined by spleen-dedicated device accurately predicted esophageal varices in cirrhosis patients.

Journal: Therapeutic advances in chronic disease

Published: March 22, 2023

Complicated etiology may influence correlation between portal pressure gradient and fibrosis staging.

Journal: Gastrointestinal endoscopy

Published: February 02, 2022

EUS-guided portal pressure gradient measurement: a promising tool in noncirrhotic portal hypertension.

Journal: Gastrointestinal endoscopy

Published: July 31, 2020